Scientist grows new medication to treat type 2 diabetes without undesired reactions Kumar Jeetendra | June 24, 2020 Syracuse University science educator Dr. Robert P. Doyle has built up another medication lead to treat type 2 diabetes in a great many patients who are looking to all the more likely control their glucose without the basic symptoms of queasiness, spewing, and in select cases, undesired weight reduction. Doyle’s examination article, “Corrination of a …
Aerogen: An appropriate aerosol drug delivery system for the effective treatment of respiratory illness Kumar Jeetendra | September 1, 2020 No matter what the respiratory illness, for mechanically ventilated or spontaneous breathing patients, Aerogen has the appropriate aerosol drug delivery system for the effective treatment of your patients. The illness includes: 1.COPD 2.Asthma 3.Cystic Fibrosis COPD Chronic Obstructive Pulmonary Disease (COPD) is among the very serious lung diseases prevalent today affecting 65 million people globally. …
Improving affectability of fluid biopsy utilizing ‘inexactly stacked’ identification layers Kumar Jeetendra | November 4, 2020 By detecting DNA fragments in body fluids like urine, some kinds of cancer may already be tracked in an early stage. But in order to capture them, detection sensitivity must be improved. Researchers at the University of Twente in The Netherlands (MESA+ Institute) use electrically charged polymers for this. Not only one layer of this, …
Conceivable new anti-microbial created for drug-resistant pulmonary microorganism Kumar Jeetendra | December 9, 2020 Scientists from Johns Hopkins University and Medicine have developed a potential new antibiotic for a pathogen that is notoriously resistant to drugs and often lethal for people with cystic fibrosis and other lung disorders. The pathogen, called Mycobacterium abscessus, is related to some better-known bacterium that causes tuberculosis and leprosy but has recently emerged as …
Microorganisms utilize vile methodology to vanquish antibody that battle cystic fibrosis Kumar Jeetendra | February 28, 2021 University of Montana researchers and their partners have found a slimy strategy used by bacteria to conquer antibiotics and other medications used to combat infections afflicting individuals with cystic fibrosis. Cystic fibrosis is a life-threatening illness which causes persistent lung infections and limits an individual’s ability to breathe over time. A frequent strain of bacteria, …
Researchers discover proof that SARS-CoV-2 infects cells in the mouth Kumar Jeetendra | March 25, 2021 An international group of scientists has discovered evidence that SARS-CoV-2, the virus that causes COVID-19, infects cells in the mouth. While it’s well known that the upper airways and lungs are primary sites of SARS-CoV-2 disease, there are clues the virus can infect cells in different parts of the body, like the digestive system, blood …
